sc 58125 has been researched along with cox 189 in 1 studies
| Studies (sc 58125) | Trials (sc 58125) | Recent Studies (post-2010) (sc 58125) | Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) |
|---|---|---|---|---|---|
| 93 | 0 | 15 | 163 | 49 | 47 |
| Protein | Taxonomy | sc 58125 (IC50) | cox 189 (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.007 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.076 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, A; Dzandzi, J; Tietz, O; Valliant, JF; Wuest, F | 1 |
1 other study(ies) available for sc 58125 and cox 189
| Article | Year |
|---|---|
Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors.
Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Iodine Radioisotopes; Molecular Docking Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Sulfones | 2016 |